CIMAvax-EGF vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CIMAvax-EGF vaccine, covering 2025-11-10 to 2025-11-10. Get the full timeline:
Most recent: Clinical Trial Update: CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer [Phase 1, Phase 2]